Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan
With
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
60 patient participants will receive either a novel DA about pregnancy and contraception in chronic kidney disease delivered by patient's nephrologist or will receive currently available educational materials based on clinic-level randomization. Nephrologists will be trained to deliver the novel decision aid or will provide usual care. Patients will complete a survey about pregnancy and contraception decision making and the acceptability and feasibility of the educational materials after the clinical visit. Intervention nephrologists will be anonymously surveyed after all patients have completed measures, to assess acceptability and feasibility.
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Any Chronic Kidney Disease (CKD) diagnosis
CKD defined as abnormality in kidney structure or function for \>3 months and may be manifested by having any one of the following:
i. Glomerular filtration rate (GFR)\<60 milliliter/Minute (ml/min)/1.73m2, or
ii. A marker of kidney damage (albuminuria \>30 milligrams per gram (mg/g), abnormal kidney histology by biopsy, hematuria, structural abnormalities by imaging (e.g. polycystic kidney disease, horseshoe kidney) or electrolyte abnormalities due to tubular disorders)
\- Able to speak and read English
You may not be if
Patients receiving dialysis
Patients who have a kidney transplant
Patients that are surgically sterile (tubal ligation or hysterectomy) or currently pregnant
Patients that have significant cognitive or visual impairment that limits interaction with the decision aid (DA)
